Concepts (299)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Endotoxemia | 8 | 2021 | 143 | 2.73 | Why? |
| DNA, Mitochondrial | 3 | 2019 | 163 | 0.86 | Why? |
| Immune Tolerance | 3 | 2020 | 608 | 0.84 | Why? |
| Ischemic Preconditioning | 1 | 2019 | 43 | 0.76 | Why? |
| von Hippel-Lindau Disease | 1 | 2017 | 9 | 0.72 | Why? |
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2017 | 13 | 0.72 | Why? |
| Sepsis | 11 | 2021 | 3517 | 0.71 | Why? |
| Kidney Tubules | 1 | 2019 | 205 | 0.68 | Why? |
| Shock, Hemorrhagic | 1 | 2018 | 81 | 0.68 | Why? |
| Cytoreduction Surgical Procedures | 1 | 2018 | 144 | 0.67 | Why? |
| Adenosine | 2 | 2018 | 509 | 0.66 | Why? |
| Hyperthermia, Induced | 1 | 2018 | 106 | 0.65 | Why? |
| Alarmins | 1 | 2018 | 180 | 0.63 | Why? |
| Adrenomedullin | 4 | 2018 | 217 | 0.60 | Why? |
| Interleukin-10 | 3 | 2018 | 1409 | 0.57 | Why? |
| Intestinal Diseases | 1 | 2017 | 231 | 0.54 | Why? |
| Precision Medicine | 4 | 2021 | 1477 | 0.54 | Why? |
| B7-H1 Antigen | 1 | 2017 | 541 | 0.52 | Why? |
| Spleen | 1 | 2017 | 877 | 0.51 | Why? |
| Lipopolysaccharides | 7 | 2021 | 848 | 0.50 | Why? |
| Shock, Septic | 2 | 2020 | 1313 | 0.49 | Why? |
| Myeloid Cells | 1 | 2017 | 808 | 0.47 | Why? |
| Neutrophils | 5 | 2021 | 5476 | 0.46 | Why? |
| Intestines | 1 | 2017 | 817 | 0.43 | Why? |
| Interferon-gamma | 2 | 2017 | 2711 | 0.42 | Why? |
| Endotoxins | 3 | 2019 | 80 | 0.39 | Why? |
| Leukocytes, Mononuclear | 2 | 2021 | 2115 | 0.37 | Why? |
| Cytokines | 12 | 2021 | 15010 | 0.33 | Why? |
| Disease Models, Animal | 4 | 2021 | 10998 | 0.33 | Why? |
| Vitamin D Deficiency | 1 | 2020 | 1782 | 0.33 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 291 | 0.29 | Why? |
| Oligopeptides | 2 | 2019 | 576 | 0.29 | Why? |
| Systemic Inflammatory Response Syndrome | 3 | 2019 | 6653 | 0.27 | Why? |
| Hypoxia | 1 | 2018 | 3626 | 0.25 | Why? |
| Netherlands | 6 | 2022 | 3533 | 0.23 | Why? |
| Antibodies | 2 | 2018 | 846 | 0.23 | Why? |
| Acute Kidney Injury | 2 | 2019 | 5762 | 0.23 | Why? |
| Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2021 | 40 | 0.23 | Why? |
| Heparin Antagonists | 1 | 2020 | 21 | 0.22 | Why? |
| Fatty Acid-Binding Proteins | 2 | 2018 | 93 | 0.21 | Why? |
| Erythroid Cells | 1 | 2020 | 82 | 0.21 | Why? |
| Endothelium | 2 | 2021 | 460 | 0.21 | Why? |
| Respiratory Burst | 1 | 2019 | 16 | 0.20 | Why? |
| Lot Quality Assurance Sampling | 1 | 2019 | 2 | 0.20 | Why? |
| Glucuronidase | 1 | 2020 | 103 | 0.20 | Why? |
| Capillary Permeability | 2 | 2018 | 277 | 0.20 | Why? |
| Euthyroid Sick Syndromes | 1 | 2021 | 150 | 0.20 | Why? |
| Receptors, Interleukin-1 | 1 | 2020 | 161 | 0.19 | Why? |
| Cells, Cultured | 7 | 2021 | 5835 | 0.19 | Why? |
| Tight Junctions | 1 | 2020 | 179 | 0.19 | Why? |
| Vasodilation | 2 | 2018 | 258 | 0.19 | Why? |
| Receptors, Purinergic P1 | 1 | 2018 | 17 | 0.19 | Why? |
| Chorionic Gonadotropin | 1 | 2018 | 30 | 0.19 | Why? |
| Phagosomes | 1 | 2018 | 32 | 0.19 | Why? |
| Guilt | 1 | 2019 | 74 | 0.19 | Why? |
| Megakaryocytes | 1 | 2020 | 274 | 0.18 | Why? |
| Claudin-3 | 1 | 2017 | 3 | 0.18 | Why? |
| Haploinsufficiency | 1 | 2017 | 28 | 0.18 | Why? |
| Inflammation | 6 | 2021 | 13255 | 0.18 | Why? |
| Citrulline | 1 | 2017 | 36 | 0.17 | Why? |
| HLA-DR Antigens | 2 | 2017 | 563 | 0.17 | Why? |
| Nocardia | 1 | 2017 | 21 | 0.17 | Why? |
| Interleukin-6 | 7 | 2020 | 7522 | 0.17 | Why? |
| Plasma Cells | 1 | 2020 | 464 | 0.17 | Why? |
| Phosphoric Diester Hydrolases | 1 | 2017 | 52 | 0.17 | Why? |
| Glucagon-Like Peptide 1 | 1 | 2017 | 83 | 0.17 | Why? |
| Interleukin-8 | 3 | 2018 | 964 | 0.17 | Why? |
| Nocardia Infections | 1 | 2017 | 37 | 0.17 | Why? |
| Norepinephrine | 1 | 2018 | 152 | 0.17 | Why? |
| Brain Abscess | 1 | 2017 | 50 | 0.16 | Why? |
| Disease Susceptibility | 2 | 2021 | 4002 | 0.16 | Why? |
| Toll-Like Receptor 9 | 1 | 2017 | 72 | 0.16 | Why? |
| Voriconazole | 1 | 2018 | 206 | 0.16 | Why? |
| Leukocytes | 3 | 2021 | 1046 | 0.16 | Why? |
| Leukemia | 2 | 2021 | 598 | 0.16 | Why? |
| Phagocytosis | 1 | 2018 | 409 | 0.16 | Why? |
| Ticlopidine | 1 | 2017 | 193 | 0.15 | Why? |
| Confidentiality | 1 | 2021 | 581 | 0.15 | Why? |
| Case Management | 1 | 2018 | 285 | 0.15 | Why? |
| Ileum | 1 | 2017 | 233 | 0.15 | Why? |
| Monocytes | 2 | 2019 | 2978 | 0.15 | Why? |
| Testosterone | 1 | 2021 | 596 | 0.15 | Why? |
| Enterocytes | 1 | 2018 | 245 | 0.15 | Why? |
| Purinergic P2Y Receptor Antagonists | 1 | 2017 | 206 | 0.15 | Why? |
| Protective Agents | 1 | 2018 | 250 | 0.15 | Why? |
| Stress, Physiological | 1 | 2019 | 378 | 0.14 | Why? |
| C-Reactive Protein | 3 | 2021 | 7972 | 0.14 | Why? |
| Invasive Fungal Infections | 1 | 2018 | 274 | 0.13 | Why? |
| Datasets as Topic | 1 | 2021 | 1404 | 0.13 | Why? |
| Inservice Training | 1 | 2018 | 477 | 0.13 | Why? |
| Vasoconstrictor Agents | 1 | 2018 | 714 | 0.13 | Why? |
| Up-Regulation | 2 | 2021 | 2249 | 0.13 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2017 | 260 | 0.13 | Why? |
| Humans | 50 | 2022 | 930598 | 0.13 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2021 | 9335 | 0.13 | Why? |
| Male | 34 | 2022 | 367725 | 0.13 | Why? |
| Platelet Activation | 1 | 2017 | 660 | 0.12 | Why? |
| Healthy Volunteers | 4 | 2021 | 1444 | 0.12 | Why? |
| Mice, Inbred C57BL | 3 | 2017 | 5542 | 0.12 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 1165 | 0.12 | Why? |
| Lymphopenia | 2 | 2021 | 2669 | 0.12 | Why? |
| Antimicrobial Stewardship | 1 | 2020 | 931 | 0.12 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.12 | Why? |
| Adaptive Immunity | 2 | 2021 | 2585 | 0.12 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2017 | 724 | 0.12 | Why? |
| Common Cold | 1 | 2018 | 645 | 0.11 | Why? |
| Rhinovirus | 1 | 2018 | 979 | 0.11 | Why? |
| Animals | 11 | 2021 | 78931 | 0.11 | Why? |
| Mitochondria | 1 | 2019 | 857 | 0.11 | Why? |
| Aged | 19 | 2022 | 215776 | 0.11 | Why? |
| Body Mass Index | 2 | 2022 | 4306 | 0.11 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.11 | Why? |
| Immunity | 2 | 2021 | 2651 | 0.11 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2020 | 1731 | 0.11 | Why? |
| Prospective Studies | 10 | 2021 | 43301 | 0.11 | Why? |
| L-Selectin | 2 | 2021 | 42 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2021 | 1724 | 0.10 | Why? |
| Obesity | 2 | 2022 | 7388 | 0.10 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.10 | Why? |
| Female | 25 | 2022 | 380317 | 0.10 | Why? |
| Biomarkers | 7 | 2021 | 23361 | 0.10 | Why? |
| Thoracic Surgery | 1 | 2017 | 623 | 0.10 | Why? |
| Pericytes | 1 | 2009 | 108 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.10 | Why? |
| Inflammation Mediators | 2 | 2017 | 2654 | 0.09 | Why? |
| Recombinant Proteins | 2 | 2017 | 3786 | 0.09 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.09 | Why? |
| Middle Aged | 20 | 2022 | 270681 | 0.09 | Why? |
| Apolipoproteins E | 1 | 2009 | 170 | 0.09 | Why? |
| Mice | 5 | 2021 | 21357 | 0.09 | Why? |
| Cerebral Amyloid Angiopathy, Familial | 1 | 2007 | 2 | 0.09 | Why? |
| Wounds and Injuries | 1 | 2021 | 1708 | 0.09 | Why? |
| Amyloid beta-Peptides | 1 | 2009 | 185 | 0.09 | Why? |
| Kidney Diseases | 1 | 2019 | 1434 | 0.09 | Why? |
| Half-Life | 2 | 2018 | 298 | 0.09 | Why? |
| Bacterial Infections | 1 | 2021 | 2229 | 0.09 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.08 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.08 | Why? |
| Astrocytes | 1 | 2009 | 298 | 0.08 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.08 | Why? |
| Endothelium, Vascular | 1 | 2018 | 1751 | 0.08 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.08 | Why? |
| Receptors, IgG | 2 | 2021 | 578 | 0.08 | Why? |
| Frontal Lobe | 1 | 2007 | 191 | 0.08 | Why? |
| Critical Illness | 5 | 2022 | 17281 | 0.08 | Why? |
| Immunity, Innate | 2 | 2021 | 6570 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Vitamin D | 1 | 2020 | 2904 | 0.07 | Why? |
| Adult | 13 | 2021 | 244371 | 0.07 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.07 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.07 | Why? |
| Heat-Shock Proteins | 1 | 2007 | 226 | 0.07 | Why? |
| Patient Acuity | 2 | 2022 | 1755 | 0.07 | Why? |
| Patient Care Team | 1 | 2018 | 3556 | 0.07 | Why? |
| Infusions, Intravenous | 2 | 2019 | 1224 | 0.06 | Why? |
| Adolescent | 8 | 2019 | 86841 | 0.06 | Why? |
| Interleukin-1beta | 2 | 2018 | 992 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Sequence Analysis, RNA | 2 | 2021 | 2290 | 0.06 | Why? |
| Blood Circulation | 1 | 2020 | 99 | 0.06 | Why? |
| Multiple Trauma | 1 | 2022 | 80 | 0.06 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.05 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Hospital Mortality | 2 | 2022 | 22087 | 0.05 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2017 | 5837 | 0.05 | Why? |
| Case-Control Studies | 4 | 2021 | 17671 | 0.05 | Why? |
| Intensive Care Units | 3 | 2022 | 29594 | 0.05 | Why? |
| Thyrotropin | 1 | 2021 | 262 | 0.05 | Why? |
| Estradiol | 1 | 2021 | 250 | 0.05 | Why? |
| Thyroid Hormones | 1 | 2021 | 213 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2019 | 11041 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Cecum | 1 | 2018 | 63 | 0.05 | Why? |
| Ligation | 1 | 2018 | 84 | 0.05 | Why? |
| Peptide Fragments | 1 | 2009 | 2075 | 0.05 | Why? |
| Punctures | 1 | 2018 | 89 | 0.05 | Why? |
| Dose-Response Relationship, Drug | 2 | 2018 | 3776 | 0.05 | Why? |
| Heparitin Sulfate | 1 | 2020 | 285 | 0.05 | Why? |
| Proglucagon | 1 | 2017 | 2 | 0.05 | Why? |
| Proprotein Convertase 1 | 1 | 2017 | 3 | 0.05 | Why? |
| Myristic Acids | 1 | 2017 | 3 | 0.05 | Why? |
| Enteroendocrine Cells | 1 | 2017 | 5 | 0.05 | Why? |
| Metabolic Clearance Rate | 1 | 2018 | 110 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.05 | Why? |
| Gonadal Steroid Hormones | 1 | 2021 | 328 | 0.05 | Why? |
| Dextran Sulfate | 1 | 2017 | 54 | 0.05 | Why? |
| Idarubicin | 1 | 2017 | 15 | 0.05 | Why? |
| Principal Component Analysis | 1 | 2021 | 689 | 0.05 | Why? |
| Glycolysis | 1 | 2019 | 208 | 0.05 | Why? |
| Biological Variation, Population | 1 | 2018 | 69 | 0.04 | Why? |
| Primates | 1 | 2021 | 584 | 0.04 | Why? |
| Intracranial Pressure | 1 | 2018 | 90 | 0.04 | Why? |
| Cytarabine | 1 | 2017 | 64 | 0.04 | Why? |
| Cell Movement | 1 | 2021 | 695 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2018 | 193 | 0.04 | Why? |
| Neuroglia | 1 | 2017 | 130 | 0.04 | Why? |
| GPI-Linked Proteins | 1 | 2018 | 317 | 0.04 | Why? |
| Calcium Signaling | 1 | 2017 | 133 | 0.04 | Why? |
| Acute Disease | 2 | 2021 | 6029 | 0.04 | Why? |
| Rats, Wistar | 1 | 2018 | 621 | 0.04 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.04 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.04 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.04 | Why? |
| Human Experimentation | 1 | 2018 | 146 | 0.04 | Why? |
| Reperfusion Injury | 1 | 2017 | 178 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Cohort Studies | 4 | 2020 | 36005 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Ferrets | 1 | 2021 | 1201 | 0.04 | Why? |
| Placebos | 1 | 2018 | 629 | 0.04 | Why? |
| Cerebrovascular Circulation | 1 | 2018 | 340 | 0.04 | Why? |
| Candida | 1 | 2019 | 425 | 0.03 | Why? |
| Greece | 1 | 2021 | 2091 | 0.03 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.03 | Why? |
| Myelodysplastic Syndromes | 1 | 2017 | 261 | 0.03 | Why? |
| Colitis | 1 | 2017 | 266 | 0.03 | Why? |
| Pneumonia, Bacterial | 1 | 2022 | 843 | 0.03 | Why? |
| Toll-Like Receptor 4 | 1 | 2017 | 390 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Cholesterol, LDL | 1 | 2017 | 499 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.03 | Why? |
| Administration, Intravenous | 1 | 2017 | 1115 | 0.03 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.03 | Why? |
| RNA | 1 | 2021 | 1278 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.03 | Why? |
| Nasal Cavity | 1 | 2018 | 909 | 0.03 | Why? |
| Length of Stay | 2 | 2022 | 11042 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| DNA | 1 | 2017 | 778 | 0.03 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.03 | Why? |
| Rats | 1 | 2018 | 2764 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Apolipoprotein E3 | 1 | 2009 | 18 | 0.03 | Why? |
| Clinical Trials as Topic | 2 | 2021 | 7330 | 0.03 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.03 | Why? |
| Chemokines | 1 | 2017 | 1095 | 0.03 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2017 | 676 | 0.03 | Why? |
| Single-Cell Analysis | 1 | 2020 | 2450 | 0.03 | Why? |
| Culture Media, Conditioned | 1 | 2009 | 66 | 0.03 | Why? |
| Cerebral Amyloid Angiopathy | 1 | 2009 | 30 | 0.03 | Why? |
| Drug Monitoring | 1 | 2018 | 1408 | 0.03 | Why? |
| Safety Management | 1 | 2018 | 1093 | 0.02 | Why? |
| Immune System | 1 | 2019 | 1479 | 0.02 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Proteomics | 1 | 2020 | 2481 | 0.02 | Why? |
| Heart Rate | 1 | 2019 | 1527 | 0.02 | Why? |
| Software | 1 | 2021 | 2501 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Apolipoprotein E4 | 1 | 2009 | 99 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2020 | 3788 | 0.02 | Why? |
| Leukocyte Count | 1 | 2019 | 3178 | 0.02 | Why? |
| Molecular Targeted Therapy | 1 | 2018 | 1579 | 0.02 | Why? |
| Hydrocortisone | 1 | 2019 | 1790 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2019 | 3347 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.02 | Why? |
| Cell Death | 1 | 2009 | 536 | 0.02 | Why? |
| Lung Diseases | 1 | 2021 | 2361 | 0.02 | Why? |
| Adjuvants, Immunologic | 1 | 2017 | 1709 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Brain | 2 | 2017 | 5133 | 0.02 | Why? |
| Plasma | 1 | 2017 | 1809 | 0.02 | Why? |
| Chronic Disease | 1 | 2021 | 5139 | 0.02 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.02 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.02 | Why? |
| Tuberculosis | 1 | 2021 | 2895 | 0.02 | Why? |
| Cell Membrane | 1 | 2009 | 743 | 0.02 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.01 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.01 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Alzheimer Disease | 1 | 2009 | 1020 | 0.01 | Why? |
| Fever | 1 | 2017 | 7795 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Genotype | 1 | 2009 | 4697 | 0.01 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2017 | 22116 | 0.01 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |